Management

Sun Pharma, Forest settle US suit on Lexapro

Sun Pharmaceutical Industries and its subsidiary, Caraco Pharmaceutical Laboratories, have reached a settlement agreement with drugmaker Forest Laboratories and licensing partner H Lundbeck AS, over a pending patent infringement dispute over Forest’s blockbuster antidepressant, Lexapro. - Sun Pharma gets USFDA nod for generic anti-cancer drug - Sun extends Taro open offer to April 17">Sun extends Taro open offer to April 17 - Sun Pharma announces US nod for Topamax tablets - Sun, Taro chiefs meet for out-of-court settlement Caraco had filed an application with the US Food and Drug Administration (USFDA) to launch a cheaper version of Lexapro, but Forest and H Lundbeck AS moved to block the drug, alleging it infringed the company’s patents. Under the agreement announced by the companies, Forest will give Caraco patents to Lexapro, when other generic versions of the drug become available. Caraco will also take over sales of certain Forest products.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Kingfisher aircraft overshoots runway; passengers safe
A Kingfisher Airlines ATR aircraft with 42 passengers and four crew onboard overshot the runway after it landed at Mumbai Airport today.
Popular Articles

Steering ahead of the taxman
The new rules on perks make it better to use the company car than to get usage reimbursed.

Bharti, RCom seek telecom corridor via Bangladesh
Indian telecom majors Bharti Airtel and Reliance Communications (RCom) have sought to build a fibre optic network in Bangladesh to get connected to the isolated north-eastern states, a report said on Sunday.

© Copyright 2009